Search
By Biotech Mag Top - 1 day ago
GENCURE PLANS ADULT STEM CELL LAB AT SAN ANTONIO “INNOVATION CENTER”
San Antonio -GenCure, a subsidiary of life sciences nonprofit BioBridge Global, expects to open a biomanufacturing laboratory this...
Science, Research, Regenerative medicine, Medicine, Biomanufacturing, Stem Cell, Life Sciences, National blog main, Texas, Texas blog main, Texas top stories, acceleration, Accelerator, Alliance of Texas Angel Networks, angel investor, Angel Network, Angel Networks, ATAN, Austral Incuba, Austral University, Becky Cap, BioBridge Global, biomanufacturing, Bioprinting, bioreactor, bioscience, bioscience indubator, Biotech, brain cell, Brazil, Cells, cellular, cellular matrix, cellular therapy, Central Texas Angel Network, Contract Manufacturing, Cybersecurity, emerging market, Emerging Technology, energy, Energy efficiency, Entrepreneur, epicenter, exome, funding, GenCure, Global Accelerator Program, Global Reach Program, Grant, Incubation, incubator, InnoBioscience, innovation, Innovation Center, international business network, Jorge Varela, Life Science, Matrix, Medical Technology Enterprise Consortium, new energy, nonprofit, pre-incubator, regeneration, Regenerative Medicine, regrowth, RoosterBio, San Antonio, San Antonio Angel Network, science, soft tissue, South America, Startup, startups, Stem Cells, StemBioSys, Tax, tax incentive, Tech, Technology, Texas Research & Technology Foundation, TexasVC, The Rivard Report, tissue generation, tissue regeneration, tissue regrowth, TRTF, U.S. Army Institute of Surgical Research, U.S. Army Medical Research and Materiel Command, Universidad Austral de Chile, Valdiva Chile, Velocity360, VelocityTX, Venture Capital, Venture Funding
More
By Biotech Mag Top - 2 days ago
ANALYST/SR. ANALYST, SALES OPERATIONS - NEUROCRINE BIOSCIENCES - SAN DIEGO, CA
Implements departmental QC processes and proactively identifies potential anomalies in data sources and alerts departmental leadership...
By Biotech Mag - 2 days ago
ARIX REAPPOINTS CEO 5 MONTHS AFTER STARTING HUNT FOR REPLACEMENT
Arix Bioscience's five-month search for a CEO has ended with it reappointing the person who vacated the role at the start of the process....
By Biotech Mag Top - 3 days ago
SUMMER INTERN - BUSINESS DEVELOPMENT - NEUROCRINE BIOSCIENCES - SAN DIEGO, CA
Pursuing an undergraduate or MBA graduate degree with an interest in biotechnology,. Prior experience in the pharmaceutical or biotechnology...
By Biotech Mag - 4 days ago
SUMMER INTERN - BRAND MARKETING - INGREZZA - NEUROCRINE BIOSCIENCES - SAN DIEGO, CA
Proven ability to quickly learn new information and communicate this to the right individual. Currently enrolled in an MBA or Master's...
By Biotech Mag Top - 6 days ago
NEW MOLECULAR BLUEPRINT ADVANCES OUR UNDERSTANDING OF PHOTOSYNTHESIS
The cryo-EM structure of the NADH dehydrogenase-like complex. The atomic coordinate model shown as spheres, colored according to the...
By Biotech Mag Top - 13 days ago
BIO ROUNDUP: NEW CRISPR FEUD, A NY SPLASH, PHARMA VS. CONGRESS & MORE
If you're into congressional spectacles, stay tuned later this month. A group of top biopharma executives-the full roster isn't known...
Pharma, BioPharma, Biopharma, Drug, Drugs, Industrial, Boston blog main, Boston top stories, Boulder, Denver blog main, Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories, Alector, Alkermes, Avrobio, baricitinib, BCMA, Bolt Biotherapeutics, Caribou Biosciences, Celgene, clinical trials, Congress, CRISPR, Darzalex, Depression, Duchenne Muscular Dystrophy, Eli Lilly, FDA, GE Ventures, Gene editing, Gene Therapy, Genentech, Gilead Sciences, GlaxoSmithKline, Gossamer Bio, Harpoon Therapeutics, HiberCell, HIV, Hunter Syndrome, Incyte, Inexia, Intellia Therapeutics, Jennifer Doudna, Johnson & Johnson, Life Sciences, MacroGenics, Medicxi, Merck KGaA, Multiple Myeloma, New York City Economic Development Corp., Olumiant, Orexia, Pain Therapeutics, President Trump, Sangamo Therapeutics, Sanofi, Sarepta Therapeutics, seres Therapeutics, Solid Biosciences, Tesaro, Trastuzumab, Xencor
More
By Biotech Mag - 14 days ago
WITH ITS FIRST HUMAN DATA, SOLID SLIPS IN DUCHENNE GENE THERAPY RACE
The race to treat Duchenne muscular dystrophy with gene therapy, a one-time, potentially long-lasting treatment, is being closely watched....
Therapies, Therapeutics, Gene, Genes, Biosciences, Gene Therapy, Boston, Boston blog main, Boston top stories, National blog main, National top stories, New York blog main, New York top stories, Alexion Pharmaceuticals, clinical trials, Duchenne Muscular Dystrophy, dystrophin, eculizumab, Eteplirsen, Exondys 51, FDA, Joseph Schwartz, Leerink, Life Sciences, Micro dystrophin, Pfizer, Sarepta Therapeutics, Solid Biosciences, Soliris
More
By Biotech Mag Top - 23 days ago
HUGE STEP FORWARD IN DECODING GENOMES OF SMALL SPECIES
For the first time, scientists have read the whole genetic code of one single tiny mosquito. Traditionally, it has been difficult to...
By Biotech Mag Top - 1 month ago
BIO ROUNDUP: AIMMUNE DRAMA, SHUTDOWN BLUES, PERLMUTTER TALKS CANCER
The partial government shutdown, now the longest in U.S. history, began to take a bite out of biotech this week, served with a hot...
Therapeutics, Cancer, Biotech, BioTech, Boston blog main, Boston top stories, Boulder, Denver blog main, Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories, Aimmune, Alnylam Pharmaceuticals, Alzheimer's disease, Alzheon, Amgen, Aptinyx, Aslan Pharmaceuticals, Brexit, Bristol-myers Squibb, Cabozantinib, cancer immunotherapy, Cirius Therapeutics, clinical trials, Eli Lilly, Evenity, Exelixis, FDA, Five Prime Therapeutics, Government Shutdown, Immunomedics, Ipilimumab, IPO, Juvenescence, Kaleido Biosciences, Life Biosciences, Life Sciences, Loxo Oncology, Merck, Nivolumab, Onpattro, Opdivo, Osteoperosis, patisiran, peanut allergy, Roger Perlmutter, romosozumab, Scott Gottlieb, Verona Pharma, Yervoy
More
By Biotech Mag Top - 1 month ago
INDIGO BIOSCIENCES ANNOUNCES RELEASE OF PREDICTIVE LIVER TOXICITY ASSAY KIT
By combining the advantages of upcyte hepatocytes with INDIGO's industry-leading platform and science, the new hepatotoxicty assay...
By Biotech Mag Top - 1 month ago
SAN DIEGO LIFE SCIENCE COMPANIES SEE STOCK BUMPS, SLIPS IN JPM WAKE
The massive life sciences meeting now known as the J.P. Morgan Healthcare Conference started out as a clubby get-together hosted by...
Science, Biotech, Biocom, Life Sciences, BioTech, Life Science, Healthcare, National blog main, San Diego, San Diego blog main, San Diego top stories, San Francisco blog main, Acadia Pharmaceuticals, Christopher Barry, Crinetics Pharmaceuticals, DexCom, Francis deSouza, HQ, Illumina, Investors, Joe Panetta, JPM, JPM Healthcare Conference, Kevin Gorman, Mirati Therapeutics, Neurocrine Biosciences, NuVasive, PacBio, Public Companies, Scott Struthers, stock, Stock Market, Trading
More
By Biotech Mag Top - 1 month ago
KALEIDO BIO AND CIRIUS JOIN AN IPO QUEUE STALLED BY FEDERAL SHUTDOWN
The partial government shutdown may have diminished staffing at the SEC but it hasn't dimmed the hopes of biotech firms hoping to go...
Therapeutics, Drugs, Drug, Biosciences, Applied, Biotech, BioTech, Boston, Boston blog main, Boston top stories, Detroit blog main, National blog main, San Diego blog main, San Diego top stories, clinical trials, Federal government shutdown 2019, Flagship Pioneering, Frazier Healthcare Partners, Government Shutdown, Hepatic Encephalopathy, hyperammonemia, investing, IPO, Kaleido Biosciences, Life Sciences, Metabolic Diseases, Microbiome, nonalcoholic steatohepatitis, Novo Holdings, Oceta Therapeutics, SEC, startups, thiazolidinedioine, urea cycle disorder
More
By Biotech Mag - 1 month ago
NOTES FROM THE JPM19 VORTEX: PRICE APOCALYPSE, CELGENE FALLOUT & MORE
[ Editor's note: Ben Fidler and Sarah de Crescenzo coauthored this report .] It is here, and then it is gone. But by the time everyone...
Healthcare, Boston blog main, Boston top stories, Boulder, Denver blog main, Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories, Acquisition, Adaptimmune, Allergan, allogeneic, Alnylam, Approval, bidding, Bill Newell, biological, Biotech, blueprint, Brad Loncar, Brent Saunders, Bristol-myers Squibb, Buyout, CAR-T, Celgene, clinical study, common sense, Democrats, Donald Trump, Doug Ingram, drug prices, Eli Lilly, fallout, FDA, female, gender gap, gene therapy duchenne muscular dystrophy, George Golumbeski, George Yancopoulos, Gilead Sciences, Giovanni Caforio, Grail, Icos, Immuno-oncology, Immunotherapy, Index, J.P. Morgan Healthcare Conference, James Noble, John Maraganore, Jounce Therapeutics, JPM19, JTX-2011, Juno Therapeutic, Kite Pharma, Kymriah, Leonard Schleifer, Life Sciences, Loxo Oncology, M&A, Manufacturing, Mark Alles, medicare, Merger, murder, Novartis, Obama, one-cheek sneak, Pfizer, plan, prediction, price gouging, Pricing, recruiter, Recruitment, Regeneron, regulation, Republicans, Richard Murray, Robin toft, San Francisco, sarepta, Scale, Scott Gottlieb, shares, Solid Biosciences, stock, Sutro Biopharma, Therapeutics, toft group, Tom Daniel, Tom Woiwode, Trial, tsunami, Versant Ventures, Westin St. Francis, women, Yescarta
More
By Biotech Mag - 1 month ago
SMRT GRANT WINNER: UNCOVERING THE METABOLIC SECRETS OF HIBERNATION
What has four legs, lots of fat and fur, and will possibly help uncover novel mechanisms to combat diabetes? Grizzly bears! If humans...
By Biotech Mag Top - 1 month ago
BIO ROUNDUP: $74B FOR CELGENE, TWO CAR-T TALES, READY FOR SF & MORE
In 2018, my Exome colleagues and I published hundreds of stories about health, medicine, the biopharma industry, government policy,...
Medicine, Health, BioPharma, Industrial, Fuel, Genome, Biopharma, Drug, Drugs, Genomics, Boston blog main, Boston top stories, Boulder, Denver blog main, Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories, AbbVie, AC Immune, Acquisition, Alliances, Alphabet, American Hpspital Association, American Medical Association, Atlas Ventures, bacteriophage, Baseline, Bioscicience, Biotech, Bristol-myers Squibb, CAR-T chimeric antigen receptor, CD39, Celgene, ceo, Chris Lowe, CMO, commissioner, Cortexyme, CRISPR-Cas3, CSO, Cydan, delay, Drug Development, drug price, early detection, Eric Dube, FDA, Filing, fundraising, Gene editing, genome editingr, Google Life Sciences, high, Immunotherapy, Infection, IPO, J.P. Morgan Healthcare, Jazz Pharmaceuticals Codiak, Johnson & Johnson, Life Sciences, Locus Biosciences, Lung Cancer, M&A, Manufacturing, Marie Kosco-Vilbois, Martin Shkreli, Merck, Michael Detke, NASH type 2 diaebets, NGM313, Oliver Rosen, Ontario Teacher' Pension Plan, Partnerships, plan, Private Equity, proposal, Retrophin, Scott Gottlieb, shutdown, Silver Lake, SMO, SQZ Biotechnologies, Stephen Aselange, supplemental fund, TCR2 therapeutics, Tiburio Therapeutics, Tizona Therapeutics, Trump administration, VC, Venture Capital, VeraCyte, Verily
More
By Biotech Mag Top - 1 month ago
PROJECT MANAGER, DRUG DEVELOPMENT - NEUROCRINE BIOSCIENCES - SAN DIEGO, CA
Neurocrine Biosciences is a San Diego based biotechnology company focused on neurologic, psychiatric and endocrine related disorders...From...
By Biotech Mag Top - 2 monthes ago
ARISTEA THERAPEUTICS RAISES $15M TO DEVELOP ANTI-INFLAMMATORY DRUGS
New biopharma company Aristea Therapeutics has raised $15 million from Novo Holdings, the Danish investment company, and secured global...
Drugs, Clinical, BioPharma, Therapeutics, Biopharma, Drug, Boston blog main, National blog main, San Diego, San Diego blog main, San Diego top stories, Ardea Biosciences, Aristea Therapeutics, AstraZeneca, Biotech, clinical trials, Drug Development, Early Stage Companies, Gout, Grünenthal, Inflammatory Disease, investment, Ironwood Pharmaceuticals, James Mackay, Ken Harrison, lesinurad, Licensing Agreement, Life Sciences, Novo Holdings, Novo Nordisk, RIST4721, SanDiegoVC, Tiba Aynechi, VC, Venture Capital, Zurampic
More
By Biotech Mag - 2 monthes ago
WITH $42M, EX-IGNYTA CEO AIMS AT CANCER AGAIN WITH STARTUP, ERASCA
Just over a year after steering cancer drug developer Ignyta into a $1.7 billion sale to Roche , Jonathan Lim is back at it again....
Therapies, Drugs, Biotech, BioTech, Drug, Cancer, Boston blog main, National blog main, San Diego, San Diego blog main, San Diego top stories, Allergan, Annexon Biosciences, ARCH Venture Partners, Autoimmune, Biogen, Biogen Idec, Bionomics, Bonti, Botox, cancer, deals, Eclipse Therapeutics, entrectinib, Entrepreneurship, Erasca, Gary Yeung, Genentech, Guardant Health, Halozyme Therapeutics, Ignyta, Jonathan Lim, Life Sciences, NexDx, Proteomics, Rheumatoid Arthritis, Robert Shoemaker, Roche, Startup Formation, startups, Stem Cells, VC, Venture Capital
More
By Biotech Mag Top - 2 monthes ago
SEER LAUNCHES TO DEVELOP LIQUID BIOPSY FOR CANCER, BRAIN DISEASE
Omid Farokhzad has, as he says, “been around the block a few times” in biotech. The cancer nanomedicine researcher has cofounded a...
Brain, BioTech, Nanomedicine, Biotech, Biosciences, Cancer, Clinical, Drug, Drugs, Research, Therapeutics, Boston blog main, Boston top stories, National blog main, San Francisco, San Francisco blog main, San Francisco top stories, Blood Tests, Bob Langer, Brigham and Womens Hospital, cancer, cancer diagnosis, cancer nanomedicine, cancer screening, Cancer-SEEK, Diagnostics, early detection, Grail, Johns Hopkins University, Life Sciences, Liquid Biopsy, nanomedicine, nanotechnology, neurological disease, Omid Farokhzad, startups
More
Pages
We are sorry, there is no page for your query.